Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Omnia Holdings Ltd | OHZ | Nov 21, 2024 | 3.72 | 0.00 |
Omnicell, Inc. | OC9 | Nov 21, 2024 | 41.60 | +5.58 |
Omnicom Group Inc. | OCN | Nov 21, 2024 | 94.10 | +2.48 |
OMV AG | OMVI | Nov 21, 2024 | 9.85 | +3.68 |
OMV AG | OMV | Nov 21, 2024 | 39.08 | +1.88 |
ON Semiconductor Corporation | XS4 | Nov 21, 2024 | 65.08 | +2.84 |
On the Beach Group plc | 9BP | Nov 21, 2024 | 1.89 | +1.61 |
Oncimmune Holdings plc | OCY | Nov 21, 2024 | 0.12 | 0.00 |
Oncoarendi Therapeutics SA | 1B1 | Nov 21, 2024 | 2.54 | +15.45 |
ONCODES.PREC.MED. EO-,34 | ZR8 | Nov 21, 2024 | 0.97 | 0.00 |
Onconova Therapeutics, Inc. | 0T2 | Nov 21, 2024 | 6.60 | 0.00 |
Oncopeptides | OND | Nov 21, 2024 | 0.08 | +4.38 |
Oncotherpapy Science Inc | 30O | Nov 21, 2024 | 0.13 | -2.90 |
OncoZenge | 8LY | Nov 21, 2024 | 0.37 | -56.14 |
ONDAS HLDGS INC. DL-,0001 | 1B8 | Nov 21, 2024 | 0.65 | +4.88 |
Onde S.A. | 0XF | Nov 21, 2024 | 2.12 | +0.71 |
Ondine Biomedical Inc | VF5 | Nov 21, 2024 | 0.07 | 0.00 |
ONE Gas, Inc. | OG9 | Nov 21, 2024 | 72.00 | 0.00 |
One Liberty Properties, Inc. | O1A | Nov 21, 2024 | 27.00 | +0.75 |
One Media iP Group Plc | 1M9 | Nov 21, 2024 | 0.02 | +2.13 |
One More Level S.A. | 1OJ | Nov 21, 2024 | 0.30 | -2.94 |
One Stop Systems, Inc. | 5MU | Nov 21, 2024 | 2.20 | +0.92 |
OneApex Limited | CWF | Nov 21, 2024 | 0.07 | 0.00 |
ONEFLOW AB | L58 | Nov 21, 2024 | 3.04 | +5.56 |
OneMain Holdings, Inc. | 0S1 | Nov 21, 2024 | 52.12 | +0.89 |
ONEOK, Inc. | ONK | Nov 21, 2024 | 110.00 | +3.07 |
OneSpan Inc. | VDY | Nov 21, 2024 | 16.50 | +3.77 |
OneSpaWorld Holdings Limited - | ORW | Nov 21, 2024 | 17.60 | +1.15 |
Onex Corp. | ONE | Nov 21, 2024 | 75.00 | 0.00 |
Ono Pharmaceutical Co. Ltd | ON4 | Nov 21, 2024 | 10.70 | +0.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.